Long-Term Efficacy and Safety of Erenumab for Episodic Migraine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Headache
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Efficacy and Safety During Open-Label Erenumab Treatment in Japanese Patients With Episodic Migraine
Headache 2021 Apr 01;61(4)653-661, F Sakai, T Takeshima, Y Tatsuoka, K Hirata, S Cheng, Y Numachi, C Peng, F Xue, DD MikolFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.